Indications and Purposes
| 1 Indications And Usage Halaven Is A Microtubule Inhibitor Indicated For The Treatment Of Patients With: Metastatic Breast Cancer Who Have Previously Received At Least Two Chemotherapeutic Regimens For The Treatment Of Metastatic Disease. Prior Therapy Should Have Included An Anthracycline And A Taxane In Either The Adjuvant Or Metastatic Setting. ( 1.1 ) Unresectable Or Metastatic Liposarcoma Who Have Received A Prior Anthracycline-Containing Regimen. ( 1.2 ) 1.1 Me Tastatic Breast Cancer Halaven Is Indicated For The Treatment Of Patients With Metastatic Breast Cancer Who Have Previously Received At Least Two Chemotherapeutic Regimens For The Treatment Of Metastatic Disease. Prior Therapy Should Have Included An Anthracycline And A Taxane In Either The Adjuvant Or Metastatic Setting [See Clinical Studies (14.1) ] . 1.2 Liposarcoma Halaven Is Indicated For The Treatment Of Patients With Unresectable Or Metastatic Liposarcoma Who Have Received A Prior Anthracycline-Containing Regimen [See Clinical Studies (14.2) ] . |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Eribulin Mesylate |
|
ZINC169344691 |